Will Decentralized Clinical Trials Compound Patient and Data Quality Risks?

Register free: http://www.appliedclinicaltrialsonline.com/act_w/dcts

Event Overview:
Decentralized Clinical Trials (DCTs) offer a more patient-centric approach in which fewer clinic visits are required and patient and caregiver burden are reduced. DCTs utilize a wide range of digital technologies to collect safety and efficacy data from study participants, normally remotely from the patient’s own home.

With the introduction of a DCT, a significant element of patient engagement is moved away from a controlled (physical) investigator and site environment, which will present significant patient and data quality risks. Additional burdens incurred by adopting this technical infrastructure include, but at not limited to; system validation, creation of patient application training materials and patient training, and study setup and configuration prior to activation/enrollment.

This webcast will focus on understanding these risks and how they can be mitigated.

Key Learning Objectives:

In this webcast we will explore:

The perceived impact of DCTs on investigative sites, studies, staff roles and patients

The perceived benefits of DCTs on conducting studies, including additional burdens inherent in this new technical infrastructure

The challenges cited to DCTs in terms of adoption by the industry

The additional quality management elements required to mitigate patient and data quality risks resulting from DCTs

The future of DCTs and the reality facing stakeholders continuing to conduct clinical trials in an industry embracing technology

Time and date: Tuesday, Oct. 29, 2019 at 1pm EDT | 12pm CDT | 10am PDT

On demand available after airing until Oct. 29, 2020.

Sponsor: Oracle Health Sciences

Register free: http://www.appliedclinicaltrialsonline.com/act_w/dcts